Chemours Narrows Losses Amid Declining Volumes
The Chemours Company (NYSE:CC) reported a narrower net loss in Q2 2026, improving from $380 million to $274 million year over year. Despite flat sales of around $1.6 billion and declining volumes across most segments—particularly in Thermal & Specialized Solutions—the company saw strong cash flow generation with free cash flow surging by 128%. This was driven partly by a price increase for Titanium Dioxide (TiO2) and improved working capital management. Adjusted EBITDA fell to $247 million, down from the prior year. Advanced Performance Materials faced its toughest quarter yet, with net sales dropping 6% due to production outages and line closures. Legal reserves tied to environmental settlements also contributed to lower earnings. Looking ahead, Chemours expects Q3 sales to decline further as demand for refrigerants cools. The stock trades at a low forward P/E of around 7x, reflecting market skepticism despite improved balance sheet metrics.
Tickers: $CC
Topics: cash flow improvement Chemours earnings report financial performance TiO2 pricing